ClinicalTrials.gg
Enrolling by invitationNCT07652710Updated Sep 30, 2026

Relationship Between Balance, Arm Function and Body Awareness in People With Stroke

An observational study in Chronic Stroke Patient, sponsored by Baskent University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Baskent University · Observational

Updated Sep 30, 2026Now Enrolling by invitationStart date movedGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
53
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Stroke is one of the leading causes of long-term disability worldwide and is frequently associated with impairments in balance, upper extremity function, and body awareness. These impairments may negatively affect independence in activities of daily living and overall quality of life. Although previous studies have investigated the relationships between balance and upper extremity function after stroke, body awareness has received relatively limited attention.

The aim of this observational cross-sectional study is to investigate the relationship between balance, upper extremity skills, and body awareness in individuals with chronic stroke. Fifty-three individuals with chronic stroke will be recruited from the Department of Physical Medicine and Rehabilitation at Baskent University Hospital.

Balance will be assessed using the Berg Balance Scale and the Tetrax computerized posturography system. Upper extremity motor impairment and functional performance will be evaluated using the Fugl-Meyer Upper Extremity Assessment and the Wolf Motor Function Test. Body awareness will be assessed using the Body Awareness Questionnaire. Additional assessments will include lower extremity motor function, muscle tone, cognitive status, shoulder range of motion, and upper extremity reaction time.

The study is expected to provide a better understanding of the relationships among balance, upper extremity function, and body awareness in individuals with chronic stroke. The findings may contribute to the development of individualized rehabilitation strategies and improve clinical assessment approaches in stroke rehabilitation.

Read the detailed description

Stroke is one of the leading causes of mortality and long-term disability worldwide and continues to represent a major public health problem. Motor, sensory, perceptual, and cognitive impairments that occur following stroke frequently result in limitations in functional independence and participation in daily life activities. Among these impairments, balance disorders and upper extremity dysfunction are particularly common and may significantly affect quality of life and rehabilitation outcomes.

Balance impairment after stroke is associated with postural instability, altered weight distribution, impaired trunk control, and an increased risk of falls. Changes in muscle tone, muscle weakness, impaired motor control, and deficits in sensory processing may negatively influence both static and dynamic balance. In addition, upper extremity impairments are observed in a large proportion of individuals with stroke and often persist into the chronic stage. Due to the complexity of upper extremity movements and the development of learned non-use, recovery of upper extremity function is generally slower and less complete than recovery of lower extremity function.

Previous studies have demonstrated associations between balance, trunk control, mobility, and upper extremity function in individuals with stroke. Impairments in upper extremity motor performance may influence postural control and balance strategies, while deficits in balance may limit functional use of the affected upper extremity. However, the interaction between these variables has not been fully clarified, particularly when functional upper extremity performance is evaluated using both clinical and objective measurement methods.

Body awareness has emerged as another important factor that may influence functional recovery following stroke. Body awareness is a multidimensional concept involving the perception and interpretation of bodily sensations, movements, and physiological states. It contributes to motor planning, movement execution, postural control, and interaction with the environment. Sensory deficits, perceptual disturbances, and motor impairments following stroke may negatively affect body awareness. Recent studies have suggested that body awareness may be associated with balance, walking ability, trunk control, upper extremity function, fear of falling, and independence in activities of daily living. Nevertheless, research examining body awareness in stroke populations remains limited.

A better understanding of the relationships among balance, upper extremity skills, and body awareness may provide valuable information for the development of individualized rehabilitation strategies. Identifying factors associated with functional performance may also contribute to the selection of appropriate assessment tools and treatment approaches in stroke rehabilitation.

The purpose of this observational cross-sectional study is to investigate the relationship between balance, upper extremity skills, and body awareness in individuals with chronic stroke. The study will be conducted at the Department of Physical Medicine and Rehabilitation, Baskent University Hospital. A total of 53 individuals with chronic stroke who meet the eligibility criteria will be included.

All assessments will be completed during a single evaluation session. Demographic and clinical information including age, sex, disease duration, dominant side, affected side, educational status, occupation, and use of assistive devices will be recorded.

Cognitive status will be assessed using the Standardized Mini-Mental State Examination (SMMSE), and only individuals scoring 24 points or higher will be included in the study. Muscle tone will be evaluated using the Modified Ashworth Scale, and only individuals with spasticity grades of 2 or 3 in the shoulder, elbow, wrist, and finger flexor muscles according to the Modified Ashworth Scale will be included in the study. Passive shoulder flexion range of motion will be measured using a goniometer, and only individuals with at least 120 degrees of shoulder flexion range of motion will be eligible for participation.

Upper and lower extremity motor impairment will be assessed using the Fugl-Meyer Assessment Scale. Upper extremity functional performance will be evaluated using the Wolf Motor Function Test.

Balance will be assessed using both clinical and objective measurement methods. Clinical balance performance will be evaluated using the Berg Balance Scale. Objective balance assessment will be performed using the Tetrax computerized posturography system, which provides measurements related to postural stability, weight distribution, and fall risk under different sensory conditions.

Upper extremity reaction time will be evaluated using the Light Trainer Flash Light Exercise System. Participants will be instructed to respond to randomly illuminated LED targets as quickly as possible, and the number of successful responses and reaction times will be recorded.

Body awareness will be assessed using the Body Awareness Questionnaire. Relationships among balance parameters, upper extremity motor and functional performance, reaction time, and body awareness scores will be analyzed using appropriate statistical methods.

Statistical analyses of the study data will be performed using SPSS software (Version 22.0). The obtained data will be expressed as mean ± standard deviation (x ± SD) and number (n%). Relationships among balance, upper extremity measurements, and body awareness will be evaluated using Pearson correlation analysis when data are normally distributed and Spearman rank correlation analysis when data are not normally distributed. In all analyses, the level of statistical significance will be accepted as p \< 0.05.

02

Conditions studied

  • Chronic Stroke Patient

Browse trials for

Keywords

  • stroke
  • postural balance
  • upper extremity
  • body image
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 53 is below the median of 152 across 1,968 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Baskent University is the lead sponsor of 209 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals with chronic stroke who are receiving outpatient follow-up and rehabilitation services at the Department of Physical Medicine and Rehabilitation, Baskent University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals who experienced a cerebrovascular event at least 6 months previously
  • Individuals between 18 and 75 years of age
  • Individuals who have experienced stroke for the first time
  • Individuals with shoulder, elbow, wrist, and finger muscle tone graded as 2 or 3 according to the Modified Ashworth Scale (MAS)
  • Individuals scoring 24 points or higher on the Standardized
  • Individuals with at least 120° of shoulder range of motion
  • Individuals who are able to walk independently or with a walking aid

Exclusion criteria

Exclusion Criteria:

  • Presence of communication problems such as difficulties in reading, writing, or speaking
  • Botulinum toxin injection within the last 3 months
  • Presence of hemispatial neglect syndrome
  • Presence of ataxia due to posterior circulation ischemia
  • Bilateral involvement (bilateral hemiparesis)
  • Having received physiotherapy within the last 6 months
  • Presence of orthopedic problems such as shoulder subluxation, shoulder pain, contracture of the hand and wrist
  • History of upper extremity or thoracic surgery
  • Presence of stroke-related visual impairments (hemianopia)
  • Presence of color blindness
  • Use of antiepileptic medication
  • History of convulsions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
53 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Berg Balance Scale Score

    To assess balance performance, the Berg Balance Scale (BBS) will be used. The scale consists of 14 functional tasks including sitting to standing, transfers, turning, reaching forward, picking up an object from the floor, and standing on one leg. Each item is scored from 0 to 4. Total scores range from 0 to 56, with higher scores indicating better balance performance.

    Time frame: Baseline (single assessment)

  2. Tetrax Fall Index

    To assess fall risk the Tetrax Computerized Posturography System will be used. Measurements will be performed under eight different sensory conditions. The Fall Index ranges from 0 to 100, with higher scores indicating a greater risk of falling.

    Time frame: Baseline (single assessment)

  3. Eyes Open Stability Index

    To assess postural stability under eyes-open conditions, the Tetrax Computerized Posturography System will be used. The Stability Index obtained during the normal standing position with eyes open will be recorded. Higher values indicate poorer postural stability.

    Time frame: Baseline (single assessment)

  4. Eyes Closed Stability Index

    To assess postural stability without visual input, participants will stand on the Tetrax Computerized Posturography System with their eyes closed. The Stability Index obtained during this condition will be recorded. Higher values indicate poorer postural stability.

    Time frame: Baseline (single assessment)

  5. Weight Distribution Index

    To assess weight distribution during standing, the Tetrax Computerized Posturography System will be used. The Weight Distribution Index will be recorded. Higher values indicate greater asymmetry in weight distribution between the supporting surfaces.

    Time frame: Baseline (single assessment)

  6. Fugl-Meyer Upper Extremity Assessment Score

    To assess upper extremity motor impairment, the Fugl-Meyer Upper Extremity Assessment will be used. The scale evaluates reflex activity, voluntary movement, coordination, and speed. Scores range from 0 to 66, with higher scores indicating better upper extremity motor function.

    Time frame: Baseline (single assessment)

  7. Wolf Motor Function Test Functional Ability Score

    Upper extremity functional ability will be assessed using the Functional Ability Scale of the Wolf Motor Function Test (WMFT). Fifteen functional tasks will be evaluated and scored on a scale from 0 to 5, with higher scores indicating better upper extremity function.

    Time frame: Baseline (single assessment)

  8. Wolf Motor Function Test Performance Time

    Upper extremity motor performance will be assessed using the Wolf Motor Function Test (WMFT). The average time required to complete the 15 functional tasks will be recorded in seconds. Shorter completion times indicate better upper extremity performance.

    Time frame: Baseline (single assessment)

  9. Body Awareness Questionnaire Score

    To assess body awareness, the Body Awareness Questionnaire will be used. The questionnaire consists of 18 items evaluating awareness of bodily processes and reactions. Total scores range from 18 to 126, with higher scores indicating greater body awareness.

    Time frame: Baseline (single assessment)

Secondary outcomes

  1. Upper Extremity Reaction Time

    Upper extremity reaction time will be assessed using the Light Trainer Flash Light Exercise System. Participants will be instructed to deactivate illuminated LED targets as quickly as possible during a 60-second test. The average time required to deactivate the illuminated targets will be recorded. Shorter reaction times indicate better performance.

    Time frame: Baseline (single assessment)

  2. Fugl-Meyer Lower Extremity Assessment Score

    Lower extremity motor function will be assessed using the Fugl-Meyer Lower Extremity Assessment. The scale consists of 17 items evaluating movement, coordination, and motor performance of the lower extremity. Total scores range from 0 to 34, with higher scores indicating better lower extremity motor function.

    Time frame: Baseline (single assessment)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2026 to primary completion in Aug 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2026
First posted
Jun 17, 2026
StartActual
Jun 18, 2026
Primary completionActual
Aug 20, 2026
CompletionEst.
Oct 20, 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Sep 30, 2026
Start date
Jun 20, 2026→Jun 18, 2026 (actual)
Sep 30, 2026
Contact
No study contact listed any more: removed d•••@hotmail.com · •••3928; removed b•••@baskent.edu.tr · •••6666
Sep 30, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Baskent University Hospital · Ankara, Turkey (Türkiye)Contact removed d•••@hotmail.com · •••3928Contact removed b•••@baskent.edu.tr · •••6666Contact removed (no phone or email listed)Contact removed (no phone or email listed)Contact removed (no phone or email listed)
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Jun 20, 2026→Jun 18, 2026 (now actual)
    Contact No study contact listed any more: removed d•••@hotmail.com · •••3928; removed b•••@baskent.edu.tr · •••6666
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Baskent University Hospital · Ankara, Turkey (Türkiye)Contact removed d•••@hotmail.com · •••3928Contact removed b•••@baskent.edu.tr · •••6666Contact removed (no phone or email listed)Contact removed (no phone or email listed)Contact removed (no phone or email listed)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07652710
Lead sponsor
Baskent University
Responsible party
Ozlem Yuruk (Prof. Dr., Baskent University) — Principal investigator
First posted
Jun 17, 2026
Start date
Jun 18, 2026
Primary completion
Aug 20, 2026
Completion
Oct 20, 2026 (estimated)
Last update
Sep 30, 2026

Study contacts

Zeliha Özlem O YÜRÜK
principal investigator · Baskent University Hospital, Department of Physical Medicine and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion